Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sabina Antonela Antoniu, Claudia Mariana Handra, Agripina Rascu, Bogdan Alexandru Barbu & Ioan Chirap Mitulschi. (2023) Navafenterol for chronic obstructive pulmonary disease therapy. Expert Opinion on Investigational Drugs 32:4, pages 283-290.
Read now
Read now
Josuel Ora, Angelo Coppola, Mario Cazzola, Luigino Calzetta & Paola Rogliani. (2020) Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 559-574.
Read now
Read now
Robert M Burkes & Ralph J Panos. (2020) Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease. Journal of Experimental Pharmacology 12, pages 589-602.
Read now
Read now
Articles from other publishers (5)
Johannes Köckenberger, Oliver Fischer, Andreas Konopa, Sebastian Bergwinkl, Susanne Mühlich, Peter Gmeiner, Roger Jan Kutta, Harald Hübner, Max Keller & Markus R. Heinrich. (2022)
Synthesis, Characterization, and Application of Muscarinergic M
3
Receptor Ligands Linked to Fluorescent Dyes
. Journal of Medicinal Chemistry 65:24, pages 16494-16509.
Crossref
Crossref
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 3, pages 100092.
Crossref
Crossref
Dave Singh. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
741
753
.
Yingmin Liang & Judith C.W. Mak. (2021) Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease. Current Pharmaceutical Design 27:12, pages 1469-1481.
Crossref
Crossref
Oliver Fischer, Josefa Hofmann, Hannelore Rampp, Jonas Kaindl, Gerald Pratsch, Amelie Bartuschat, R. Verena Taudte, Martin F. Fromm, Harald Hübner, Peter Gmeiner & Markus R. Heinrich. (2020) Regiospecific Introduction of Halogens on the 2-Aminobiphenyl Subunit Leading to Highly Potent and Selective M3 Muscarinic Acetylcholine Receptor Antagonists and Weak Inverse Agonists. Journal of Medicinal Chemistry 63:8, pages 4349-4369.
Crossref
Crossref